Chapter 10 The Development of Venture-Capital-Backed and Independent Companies: An Empirical Study Among Germany's Internet and E-Commerce Start-UpsStephan Golla et al.The Development of Venture-Capital-Backed and Independent Companies: An Empirical Study Among Germany's Internet and E-Commerce Start-Ups

Author(s):  
Stephan Golla ◽  
Martin Holi ◽  
Tobias Johann ◽  
Heinz Klandt ◽  
Lutz Kraft
Author(s):  
Manish Kumar Maurya

Nowadays, Organizations especially the start-ups concentrate so much in adding values to the product and services that it hardly adds value to their own employees. Mass layoffs and shutting down businesses are few examples of that.This paper attempts to increase an understanding of a different approach towards entrepreneurship. It basically takes into account the roles venture capital financing play in supporting entrepreneurial activity and an alternative to it by introducing the concept of grafting entrepreneurship and its implications.


SAGE Open ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. 215824402110074
Author(s):  
Zhiyi Qiu ◽  
Rong Chen ◽  
Ye Yang

Cross-border venture capitals (CBVCs) are increasingly prevailing in recent decades, inter alia in emerging markets like China. The venture capital (VC) firms investing outside their home countries are faced with foreignness which is broadly regarded as liability. The primary aim of this article is to contribute to our understanding how foreignness affects VC’s strategy when entering emerging markets, particularly with respect to the foreignness originated from cultural distance. The data consist of over 5,000 CBVC deals taking place in China mainland from 1988 to 2016. Our empirical study shows that, with foreignness growing, it turns from liability into advantage in the context of CBVCs. We find an inverse U-shape relationship between foreignness and syndication, with VC firm’s reputation as the moderator. Besides, foreign VC firms establish local subsidiary when faced with foreignness, which serves as alternative to syndication. The key contribution of this article is that foreignness turns from liability into advantage in emerging markets, which exerts a curvilinear impact on the entry strategy of VC firms. This study advances the knowledge of foreignness and VC strategy, and sheds new light on entrepreneurial activities in emerging markets.


2010 ◽  
Vol 12 (4) ◽  
pp. 261-266 ◽  
Author(s):  
Massimo G. Colombo ◽  
Terttu Luukkonen ◽  
Philippe Mustar ◽  
Mike Wright
Keyword(s):  

2017 ◽  
Vol 7 (1) ◽  
pp. 75-81
Author(s):  
Simon Zaby

This paper aims to investigate success factors of innovative start-up firms from the perspective of young start-up managers. Which key factors did they experience before and since the foundation of their company? The experience from the quite young Swiss start-up scene pro-vides important insights to entrepreneurs and policy-makers in emerging countries that cur-rently face the necessity of building up a start-up environment. One part of the data has been collected by the author, the other part originates from the Swiss Venture Capital Database (total sample size: 306). The results show a significant role of venture capital financing for the success of innovative start-ups. Interestingly, this is to some extent because the start-ups see various additional benefits from venture capitalists involved in their firm. Thus, the findings shed new light on a proper definition of venture capital that should not solely focus on the flow of funds.


Author(s):  
Michael Kinch

Despite and arguably because of the enormous public health benefits arising from the introduction of new medicines, the industry is in the midst of crisis. We detail in this chapter the decline in research and development efficiency, which has been termed “Eroom's Law,” a playful inversion of the bettern known Moore's Law of Computing. An explanation of declining efficiency follows as is a brief summary of some remedies taken by many biopharmaceutical entities, including the abandonment of therapeutics targeting particularly difficult indications such as Alzheimer's disease and antibiotics. We also convey how the industry has developed into a sort of food chain, with smaller companies and government grants supporting the earliest stages of research, which are then acquired by medium-sized companies, which in turn are consolidated into large companies. This food chain is fundamentally in doubt based on shrinking Federal spending on research combined with a decline in venture capital support for early-stage start-ups.


Author(s):  
Dan Breznitz

“But,” some readers might say, “look at Israel, look at San Diego—it is still feasible to become a Silicon-Hyphen.” To which this chapter answers: “And would it be a good idea if it is?” The chapter opens the mind of the reader to new ways of thinking about innovation and growth. Providing a frontal attack on the start-up religion and its most important commandment: using venture capital (VC) as a basis for growth. VCs have attained the paradigmatic status of a “must-have,” institution, when in fact they are just one, not very successful, solution to solving the question of how to finance innovation. The chapter does it by explaining how VCs really work and make money (and for whom), where and when they are successful (rarely and only in ICT and biotech), what does that means to the companies they finance, who is allowed to be part of this party, and what are the impacts on communities in places where the VCs are successful (inequality levels last seen in the Gilded Age). It utilizes research on Israel and Silicon Valley to drive those points home. At the end of the chapter the reader should realize that, YES, they want innovation-based growth, but NO, even if they could make it happen, the last thing they want for their community is to become a Silicon-Valley/Israel look-alike.


Sign in / Sign up

Export Citation Format

Share Document